I am extremely excited to join the faculty at Washington University! My practice philosophy hopes to balance the science of medicine with a holistic approach to patient care. As a result, I am committed to developing individualized diagnostic and treatment plans based on a patient and family’s specific needs. In particular, I pride myself on communication, and therefore hope to clearly articulate the complex aspects of endocrinology and diabetes in a practical and digestible manner. Furthermore, I hope to offer the latest advances in modern endocrinology and diabetes technology available to my patients.
My clinical interests include utilizing insulin pumps and continuous glucose monitors in the management of children with diabetes. I am a co-leader of a multidisciplinary team for the use of technology in caring for children with diabetes. In addition to type 1 diabetes, I have experience managing patients with rare forms of diabetes. This includes monogenic diabetes, Wolfram syndrome, and pancreatectomy related diabetes. Additionally, I have strong interest in managing disorders of the thyroid gland including Hashimoto’s and Graves’ disease.
Beyond patient care, I spend a significant amount of my time working as a physician-scientist studying novel treatments and therapies for children with diabetes. My research is focused on developing strategies aimed at protecting, regenerating, and replacing the insulin producing beta cells of the pancreas. In order to accomplish this, I study disease processes related to an important intracellular organelle, the endoplasmic reticulum. My goal is to identify biomarkers of endoplasmic reticulum health. These findings will help develop a new and exciting class of medications that can be used to treat childhood diabetes and other endocrine conditions. In addition to working in the lab, I study patients who have atypical or rare presentations of diabetes. By understanding the differences in these patients' genetics and physiology I hope to gain an understanding of the key pathways and biomarkers involved in beta cell biology. I am hopeful that these strategies can help lead to new paradigms in the treatment of diabetes and other endocrine conditions.
In my free time I enjoy exploring St. Louis with my family. My hobbies include drawing, illustration, fishing, and bicycling.